Caxton Associates
Caxton Associates LP is a $7.6 billion New York-based hedge fund, founded in 1983 by Bruce Kovner.
Caxton Associates' primary business is to manage client and proprietary capital through global macro hedge fund strategies as well as other alternative investment disciplines.
Caxton employs over 205 people at its offices in New York, Princeton, NJ and London.
View Older Stories View More Recent Stories
-
Form 13F-HR CAXTON CORP For: Jun 30
-
Form D/A Caxton Global Investment
-
Form SC 13G/A AGILE THERAPEUTICS INC Filed by: CAXTON CORP
-
Form SC 13G Garrison Capital Inc. Filed by: CAXTON CORP
-
Investors stick with macro funds, hope for volatility comeback
-
Form D/A HedgeForum Caxton, LLC
-
Euro nears two-year high as ECB flags autumn tightening talk
-
Caxton's Berkowitz and six others leave as hedge fund cuts fees; hedge fund said down 8% through May - Bloomberg
-
Form 13F-HR CAXTON ASSOCIATES LP For: Mar 31
-
Form 13F-HR CAXTON CORP For: Mar 31
-
Juilliard Names Damian Woetzel As Seventh President
-
Revolutionary Global Cryptocurrency Crowdfunding Platform, FundYourselfNow Set for Official Launch in Q1 2018
-
Form SC 13G International Seaways, Filed by: CAXTON INTERNATIONAL LTD
-
Form SC 13G International Seaways, Filed by: CAXTON ASSOCIATES LP
-
Blenheim Capital Management Announces Partnership Appointments
-
Investors flock to 'macro' hedge funds, but not only the old guard
-
Sterling climbs, shares fall, after Brexit formally triggered
-
Form 13F-HR CAXTON ASSOCIATES LP For: Dec 31
-
Form 13F-HR CAXTON CORP For: Dec 31
-
Form SC 13G/A PLY GEM HOLDINGS INC Filed by: Caxton-Iseman (Ply Gem), L.P.
-
Form SC 13G/A AGILE THERAPEUTICS INC Filed by: CAXTON CORP
-
Big Sky Partners Expands Unique Consulting Platform to Accelerate Brands, Empower Founders, and Provide Investments
-
Form SC 13D Strongbridge Biopharma Filed by: CAXTON CORP
-
Hedge funds slow to adjust champagne tastes to beer budgets
-
Form 13F-HR/A CAXTON ASSOCIATES LP For: Sep 30
-
Form 13F-HR CAXTON ASSOCIATES LP For: Sep 30
-
Form 13F-HR CAXTON CORP For: Sep 30
-
Exclusive: Ackman's Pershing Square shakes up fees amid losses
-
Chiron Investment Management Bolsters Distribution as AUM and Availability Continues to Grow
-
Juilliard President Joseph W. Polisi Announces Intention To Step Down In June 2018
-
Brevan Howard hedge fund axes management fees for some current investors
-
Hedge funds across globe cut fees in battle for investors
-
Jacobs Wins Further Contract for Highways England’s Roads Investment Program
-
Jana exits gold in second quarter as price rises to two-year high
-
Form 13F-HR CAXTON CORP For: Jun 30
-
Form 13F-HR CAXTON ASSOCIATES LP For: Jun 30
-
Form D/A Caxton Global Investment
-
Form SC 13D/A SYNTA PHARMACEUTICALS Filed by: CAXTON CORP
-
Form SC 13D/A SYNTA PHARMACEUTICALS Filed by: CAXTON CORP
-
Form SC 13D/A OVERSEAS SHIPHOLDING Filed by: CAXTON INTERNATIONAL LTD
-
Form SC 13D/A OVERSEAS SHIPHOLDING Filed by: CAXTON ASSOCIATES LP
-
Form SC 13D/A Celator Pharmaceuticals Filed by: CAXTON CORP
-
Form 4 Celator Pharmaceuticals For: Jul 12 Filed by: CAXTON CORP
-
martinwolf Announces New York Office, Executive Promotion
-
Hedge fund firm Caxton up 2 percent on Friday after Brexit vote: source
-
Form SC 13D/A Celator Pharmaceuticals Filed by: CAXTON CORP
-
Kodak Demonstrates Leadership Through Innovation at drupa 2016 with Outstanding Results
-
Form SC 13D/A Celator Pharmaceuticals Filed by: CAXTON CORP
-
Form D/A HedgeForum Caxton, Ltd.
-
Form 13F-HR CAXTON CORP For: Mar 31

